1. FRI0171 Achieving long-term comprehensive disease control with adalimumab and methotrexate in patients with early rheumatoid arthritis in the optima study. (23rd January 2014) Authors: Emery, P.; Smolen, J.S.; Fleischmann, R.; van Vollenhoven, R.; Florentinus, S.; Santra, S.; Kupper, H.; Redden, L.; Kavanaugh, A. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 369 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0122 Efficacy of addition, or continuation, of adalimumab in patients who did not achieve stable low disease activity with methotrexate or adalimumab plus methotrexate in the optima study. (23rd January 2014) Authors: Kavanaugh, A.; Fleischmann, R.; Emery, P.; van Vollenhoven, R.; Florentinus, S.; Shaw, J.W.; Santra, S.; Kupper, H.; Redden, L.; Smolen, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗